IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 50,800
+100 (0.20%)
At close: Feb 27, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 762.61 billion as of February 27, 2026.
Market Cap
762.61B
Enterprise Value
742.39B
Revenue
1.68B
Ranking
n/a
PE Ratio
n/a
Stock Price
50,800.00
Market Cap Chart
Since May 23, 2025, IntoCell's market cap has increased from 492.33B to 762.61B, an increase of 54.90%. That is a compound annual growth rate of 76.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 762.61B | -11.43% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 1.62T |
| Qurient | 1.36T |
| JS Link | 1.25T |
| Inventage Lab | 1.09T |
| ROKIT Healthcare | 977.59B |
| Curocell | 783.67B |
| HansBiomed | 692.96B |
| S.Biomedics | 474.97B |